Ship Healthcare Holdings Inc (JP:3360)
:3360
Top Page
Ship Healthcare Holdings
(3360)
Select Model
Select Model
Rating:75Outperform
Price Target:
¥2,597.00
▼(-2.75% Downside)
Action:ReiteratedDate:11/28/25
Ship Healthcare Holdings scores well due to its strong financial performance and bullish technical indicators. The company's consistent revenue growth and financial stability are significant strengths. However, the stock's valuation is fair, and technical indicators suggest it may be nearing overbought levels, which could limit short-term upside.
Positive Factors
Revenue Growth
Consistent revenue growth indicates strong market demand and effective business strategies, enhancing the company's competitive position in the healthcare sector.
Negative Factors
Cash Reserves
Decreasing cash reserves could limit the company's ability to quickly respond to unforeseen expenses or investment opportunities, potentially impacting liquidity.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth
Consistent revenue growth indicates strong market demand and effective business strategies, enhancing the company's competitive position in the healthcare sector.
Read all positive factors
Ship Healthcare Holdings (3360) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥206.70B
Dividend Yield2.19%
Average Volume (3M)255.53K
Price to Earnings (P/E)15.3
Beta (1Y)0.61
Revenue Growth8.90%
EPS Growth-3.71%
CountryJP
Employees7,793
SectorHealthcare
Sector Strength45
IndustryMedical - Instruments & Supplies
Share Statistics
EPS (TTM)42.70
Shares Outstanding94,350,136
10 Day Avg. Volume330,690
30 Day Avg. Volume255,526
Financial Highlights & Ratios
PEG Ratio1.30
Price to Book (P/B)1.27
Price to Sales (P/S)0.28
P/FCF Ratio11.42
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
¥3,440.00Price Target Upside28.81% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)176.5
Revenue Forecast (FY)¥713.22B
Ship Healthcare Holdings Business Overview & Revenue Model
Company Description
Ship Healthcare Holdings, Inc. engages in the medical, healthcare, welfare, and nursing care businesses worldwide. It operates through four segments: Total Pack Produce Business, Medical Supply Business, Lifecare Business, and Dispensing Pharmacy ...
Ship Healthcare Holdings Financial Statement Overview
Summary
Income Statement
85
Very Positive
Balance Sheet
78
Positive
Cash Flow
80
Positive
| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 686.32B | 678.23B | 630.99B | 572.28B | 514.35B | 497.16B |
| Gross Profit | 66.79B | 66.74B | 65.61B | 60.62B | 53.64B | 54.49B |
| EBITDA | 31.50B | 32.16B | 31.88B | 28.61B | 26.23B | 26.30B |
| Net Income | 14.09B | 15.13B | 13.80B | 12.06B | 12.17B | 12.28B |
Balance Sheet | ||||||
| Total Assets | 367.17B | 381.70B | 387.56B | 381.98B | 335.07B | 334.50B |
| Cash, Cash Equivalents and Short-Term Investments | 80.57B | 77.50B | 85.07B | 80.92B | 73.90B | 74.01B |
| Total Debt | 31.56B | 39.30B | 59.87B | 76.01B | 63.41B | 67.31B |
| Total Liabilities | 220.75B | 231.42B | 245.33B | 250.86B | 212.75B | 219.39B |
| Stockholders Equity | 145.32B | 149.08B | 139.53B | 128.04B | 118.29B | 111.44B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 16.56B | 28.42B | 10.64B | 9.30B | 15.14B |
| Operating Cash Flow | 0.00 | 20.38B | 31.61B | 14.11B | 12.43B | 19.77B |
| Investing Cash Flow | 0.00 | -4.03B | -7.20B | -6.77B | -3.87B | -19.29B |
| Financing Cash Flow | 0.00 | -24.62B | -20.48B | -1.02B | -8.84B | -10.46B |
Ship Healthcare Holdings Technical Analysis
Negative
2670.50
Price Trends
2615.80
Negative
2592.24
Negative
2376.16
Negative
Market Momentum
-77.82
Positive
34.46
Neutral
13.38
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3360, the sentiment is Negative. The current price of 2670.5 is above the 20-day moving average (MA) of 2515.15, above the 50-day MA of 2615.80, and above the 200-day MA of 2376.16, indicating a bearish trend. The MACD of -77.82 indicates Positive momentum. The RSI at 34.46 is Neutral, neither overbought nor oversold. The STOCH value of 13.38 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:3360.
Ship Healthcare Holdings Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥206.70B | 15.29 | 9.53% | 2.19% | 8.90% | -3.71% | |
71 Outperform | ¥845.61B | 16.38 | 9.38% | 1.88% | 1.51% | -12.59% | |
67 Neutral | ¥3.09T | 25.64 | 8.98% | 1.22% | 7.68% | 10.08% | |
60 Neutral | ¥1.55T | 38.56 | 11.34% | 1.01% | 0.42% | 34.76% | |
54 Neutral | ¥240.89B | 5.59 | 4.38% | 2.03% | 6.04% | 733.13% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
* Healthcare Sector Average
JP:3360
Ship Healthcare Holdings
2,375.00
393.40
19.85%
JP:4543
Terumo
2,088.50
-692.46
-24.90%
JP:8086
Nipro
1,507.00
186.58
14.13%
JP:7733
Olympus
1,408.00
-603.37
-30.00%
JP:6869
Sysmex
1,356.00
-1,406.70
-50.92%
Ship Healthcare Holdings Corporate Events
Ship Healthcare Reshapes Top Management and Board Structure
Mar 6, 2026
Ship Healthcare Holdings announced a reshuffle of its top management, with Director and Vice Chairman Kenzo Konishi becoming Representative Director effective April 1, 2026, following a change prompted by personal reasons. The move signals an adju...
Ship Healthcare Revamps Nomination and Compensation Committee to Bolster Governance
Feb 6, 2026
Ship Healthcare Holdings has revised the composition of its voluntary Nomination and Compensation Advisory Committee, effective February 6, 2026, to strengthen the independence and objectivity of processes for appointing, dismissing, and remunerat...
Ship Healthcare Grows Sales but Profits Slip as Group Restructuring Advances
Feb 6, 2026
SHIP HEALTHCARE HOLDINGS reported a 6.1% year-on-year increase in net sales to ¥522.4 billion for the nine months ended December 31, 2025, but operating profit fell 4.4% and profit attributable to owners of parent declined 10.8%, reflecting m...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.